Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06399302 · ClinicalTrials.gov registry record

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

A clinical trial of Lung Transplant; Complications and Lung Transplant Rejection, sponsored by Duke University.

Recruiting
Registry status
2,600
Enrollment target
17
Study locations

NCT06399302 is a study of Lung Transplant; Complications and Lung Transplant Rejection that is actively recruiting participants, run by Duke University. The registered enrollment target is 2,600 participants, above the 143-participant average among 6 other Lung Transplant; Complications trials with a reported enrollment target (1718% higher). The trial reports 17 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06399302, a study of Lung Transplant; Complications and Lung Transplant Rejection, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
2,600 participants
Enrollment target
17
Study locations

Study Summary

This project aims to collect detailed clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients at Lung Transplant Centers. The goal is to create a robust resource for various research objectives, including studying the impact of variations in donor and medical practices on clinical outcomes. The project also seeks to identify serum biomarkers associated with or predictive of specific post-transplant complications and conditions.

Conditions Studied

Lung Transplant; Complications Lung Transplant Rejection Lung Transplant; Infection or Inflammation Lung Transplant Failure

Study Locations (17)

California

  • University of California Los Angeles - Los Angeles
  • University of California at San Francisco - San Francisco

New York

  • New York University - New York
  • Columbia University - New York

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

Florida

  • University of Miami - Miami

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Brigham and Womens Hospital - Boston

Michigan

  • University of Michigan - Ann Arbor

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 2,600 participants
Start Date 2024-09-03
Est. Completion 2027-06-30

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06399302

The ClinicalTrials.gov registry entry for NCT06399302 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 143-participant average among 6 other Lung Transplant; Complications trials with a reported enrollment target (1718% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Lung Transplant; Complications appearing as the primary indexed condition, and to 0 interventions.

NCT06399302 reports 17 study locations spanning 14 distinct geographic areas - top geographies include California, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06399302 about?

NCT06399302 is a clinical study titled "Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes". This project aims to collect detailed clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients at Lung Transplant Centers. The goal is to create a robust resource for various research objectives, including studying the impact of variat...

What is the current status of trial NCT06399302?

This trial is currently recruiting. The enrollment target is 2,600 participants. The study started on 2024-09-03. Estimated completion is 2027-06-30.

What conditions does trial NCT06399302 study?

This clinical trial studies the following conditions: Lung Transplant; Complications, Lung Transplant Rejection, Lung Transplant; Infection or Inflammation, Lung Transplant Failure.

Who is sponsoring clinical trial NCT06399302?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06399302 being conducted?

This trial has 17 study locations across California, Florida, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Transplant; Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Transplant; Complications

All registered trials for this condition

Lung Transplant Rejection

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.